| Metric | FY 2026 | Prior Q | FY 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.6B | — | $1.4B | — | 12.7% |
| Op. Income | $61M | — | -$163M | — | 137.5% |
| Gross Margin | 83.0% | — | 82.7% | — | 0.3pp |
| Net Margin | 17.5% | — | -5.2% | — | 22.7pp |
| EPS (Diluted) | $0.52 | — | $-0.13 | — | 500.0% |
| Free Cash Flow | $352M | — | $306M | — | 15.2% |
| Item | Amount |
|---|---|
| REVENUE | $1.6B |
| Cost of Revenue | $274M |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $385M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $890M |
| Other Expenses | $0 |
| Operating Expenses | $1.3B |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $61M |
| Interest Income | $48M |
| Interest Expense | $0 |
| Other Income/Expenses | $40M |
| INCOME BEFORE TAX | $101M |
| Income Tax Expense | -$182M |
| Net Income from Continuing Ops | $282M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $282M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $282M |
| D&A | $17M |
| EBIT | $61M |
| EBITDA | $78M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $1.6B |
| Cost of Revenue | $274M |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $385M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $890M |
| Other Expenses | $0 |
| Operating Expenses | $1.3B |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $61M |
| Interest Income | $48M |
| Interest Expense | $0 |
| Other Income/Expenses | $40M |
| INCOME BEFORE TAX | $101M |
| Income Tax Expense | -$182M |
| Net Income from Continuing Ops | $282M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $282M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $282M |
| D&A | $17M |
| EBIT | $61M |
| EBITDA | $78M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $282M |
| Depreciation & Amortization | $17M |
| Stock-Based Compensation | $291M |
| Deferred Income Tax | -$203M |
| Other Non-Cash Items | $133M |
| Change in Working Capital | -$149M |
| OPERATING CASH FLOW | $371M |
| Capital Expenditure | -$19M |
| Acquisitions (Net) | -$25M |
| Purchases of Investments | -$772M |
| Sales/Maturities of Investments | $809M |
| Other Investing Activities | -$15M |
| NET CASH FROM INVESTING | -$22M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$329M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$59M |
| NET CASH FROM FINANCING | -$372M |
| FREE CASH FLOW | $352M |
| Net Change in Cash | -$8M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $871M |
| Short-Term Investments | $601M |
| Net Receivables | $581M |
| Inventory | $0 |
| Other Current Assets | $191M |
| TOTAL CURRENT ASSETS | $2.2B |
| PP&E (Net) | $110M |
| Goodwill | $125M |
| Intangible Assets | $20M |
| Long-Term Investments | $0 |
| Tax Assets | $233M |
| Other Non-Current Assets | $446M |
| TOTAL NON-CURRENT ASSETS | $935M |
| TOTAL ASSETS | $3.2B |
| Account Payables | $10M |
| Short-Term Debt | $0 |
| Deferred Revenue | $604M |
| Other Current Liabilities | $292M |
| TOTAL CURRENT LIABILITIES | $905M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $104M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $17M |
| TOTAL NON-CURRENT LIABILITIES | $191M |
| TOTAL LIABILITIES | $1.1B |
| Common Stock | $6.0K |
| Additional Paid-In Capital | $4.6B |
| Retained Earnings | -$1.7B |
| Treasury Stock | -$834M |
| Accum. Other Comp. Income | $37M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.1B |
| TOTAL LIABILITIES & EQUITY | $3.2B |
| Total Debt | $71M |
| Net Debt | -$800M |
